These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29032103)

  • 1. Mast cells in atherosclerotic cardiovascular disease - Activators and actions.
    Kovanen PT; Bot I
    Eur J Pharmacol; 2017 Dec; 816():37-46. PubMed ID: 29032103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of mast cells in the pathogenesis of atherosclerosis].
    Czyzewska-Buczyńska A; Witkiewicz W
    Przegl Lek; 2011; 68(3):171-4. PubMed ID: 21812235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells and degradation of pericellular and extracellular matrices: potential contributions to erosion, rupture and intraplaque haemorrhage of atherosclerotic plaques.
    Kovanen PT
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):857-61. PubMed ID: 17956232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells in atherogenesis: actions and reactions.
    Kovanen PT
    Curr Atheroscler Rep; 2009 May; 11(3):214-9. PubMed ID: 19361353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells in atherosclerosis.
    Bot I; Biessen EA
    Thromb Haemost; 2011 Nov; 106(5):820-6. PubMed ID: 21866302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of mast cells in atherosclerosis.
    Wezel A; Quax PH; Kuiper J; Bot I
    Hamostaseologie; 2015; 35(2):113-20. PubMed ID: 25377048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries.
    Laine P; Naukkarinen A; Heikkilä L; Penttilä A; Kovanen PT
    Circulation; 2000 Apr; 101(14):1665-9. PubMed ID: 10758048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells.
    Lappalainen J; Lindstedt KA; Oksjoki R; Kovanen PT
    Atherosclerosis; 2011 Feb; 214(2):357-63. PubMed ID: 21163482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells as effectors in atherosclerosis.
    Bot I; Shi GP; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):265-71. PubMed ID: 25104798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells in human fatty streaks and atheromas: implications for intimal lipid accumulation.
    Kovanen PT
    Curr Opin Lipidol; 1996 Oct; 7(5):281-6. PubMed ID: 8937517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanilloid receptor TRPV1, sensory C-fibers, and activation of adventitial mast cells. A novel mechanism involved in adventitial inflammation.
    Hu CL; Xiang JZ; Hu FF
    Med Hypotheses; 2008; 71(1):102-3. PubMed ID: 18359578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adventitial inflammation: a possible pathogenic link to the instability of atherosclerotic plaque.
    Hu CL; Xiang JZ; Hu FF; Huang CX
    Med Hypotheses; 2007; 68(6):1262-4. PubMed ID: 17161549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells promote atherosclerosis by releasing proinflammatory cytokines.
    Sun J; Sukhova GK; Wolters PJ; Yang M; Kitamoto S; Libby P; MacFarlane LA; Mallen-St Clair J; Shi GP
    Nat Med; 2007 Jun; 13(6):719-24. PubMed ID: 17546038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid droplets in activated mast cells - a significant source of triglyceride-derived arachidonic acid for eicosanoid production.
    Dichlberger A; Schlager S; Kovanen PT; Schneider WJ
    Eur J Pharmacol; 2016 Aug; 785():59-69. PubMed ID: 26164793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mast cells in atherosclerosis: a classical inflammatory disease.
    Spinas E; Kritas SK; Saggini A; Mobili A; Caraffa A; Antinolfi P; Pantalone A; Tei M; Speziali A; Saggini R; Conti P
    Int J Immunopathol Pharmacol; 2014; 27(4):517-21. PubMed ID: 25572731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae and atherosclerosis: the role of mast cells.
    Di Pietro M; Schiavoni G; Del Piano M; Shaik Y; Boscolo P; Caraffa A; Grano M; Teté S; Conti F; Sessa R
    J Biol Regul Homeost Agents; 2009; 23(2):65-9. PubMed ID: 19589286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression.
    Wezel A; Lagraauw HM; van der Velden D; de Jager SC; Quax PH; Kuiper J; Bot I
    Atherosclerosis; 2015 Aug; 241(2):289-96. PubMed ID: 26062988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mast cell as a pluripotent HDL-modifying effector in atherogenesis: from in vitro to in vivo significance.
    Lee-Rueckert M; Kovanen PT
    Curr Opin Lipidol; 2015 Oct; 26(5):362-8. PubMed ID: 26339766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late Lesions.
    Kovanen PT
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture.
    Lindstedt KA; Kovanen PT
    Curr Opin Lipidol; 2004 Oct; 15(5):567-73. PubMed ID: 15361793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.